These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15465100)

  • 1. Unusual neuro-ophthalmologic findings in a patient with anti-Yo-associated cerebellar degeneration.
    Cohen AB; Zupa-Fernandez A; Dalmau J; Galetta SL
    J Neurol Sci; 2004 Oct; 225(1-2):153-5. PubMed ID: 15465100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K; Tanaka M; Onodera O; Tsuji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma].
    Holzmann P; Holy D; Stillhard G; Janda M; Möbr P
    Schweiz Med Wochenschr; 1998 Jun; 128(23):906-8. PubMed ID: 9658519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Idezuka J; Tsuji S
    Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA antigens in paraneoplastic cerebellar degeneration associated with anti-Yo antibody.
    Tanaka M; Tanaka K; Tsuji S
    Neurodegeneration; 1994 Dec; 3(4):341-2. PubMed ID: 7842305
    [No Abstract]   [Full Text] [Related]  

  • 6. Long term course of change in anti-Yo antibody content in paraneoplastic cerebellar degeneration.
    Tanaka K; Tanaka M; Igarashi S; Onodera O; Nakajima T; Yamazaki M; Miyatake T; Tsuji S
    J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):256-7. PubMed ID: 7876871
    [No Abstract]   [Full Text] [Related]  

  • 7. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
    Tanaka K; Tanaka M; Onodera O; Igarashi S; Tsuji S
    No To Shinkei; 1994 Jan; 46(1):47-51. PubMed ID: 8136199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
    Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
    Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
    Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
    Xia K; Saltzman JR; Carr-Locke DL
    MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients.
    Peterson K; Rosenblum MK; Kotanides H; Posner JB
    Neurology; 1992 Oct; 42(10):1931-7. PubMed ID: 1407575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.
    Verschuuren J; Chuang L; Rosenblum MK; Lieberman F; Pryor A; Posner JB; Dalmau J
    Acta Neuropathol; 1996; 91(5):519-25. PubMed ID: 8740233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Shinozawa K; Idezuka J; Tsuji S
    J Neurol Sci; 1998 Nov; 161(1):88-90. PubMed ID: 9879687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease.
    Hammack J; Kotanides H; Rosenblum MK; Posner JB
    Neurology; 1992 Oct; 42(10):1938-43. PubMed ID: 1407576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
    Tanaka M; Tanaka K; Onodera O; Tsuji S
    Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo").
    Lennon VA; Kryzer TJ
    Neurology; 1998 Jul; 51(1):327-9. PubMed ID: 9674845
    [No Abstract]   [Full Text] [Related]  

  • 19. [A candidate peptide reacting with cytotoxic T cells in paraneoplastic cerebellar degeneration with anti-Yo antibody].
    Tanaka M; Tanaka K
    Rinsho Shinkeigaku; 1999 Jun; 39(6):603-5. PubMed ID: 10502981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominant downgaze ophthalmoparesis in anti-Hu encephalomyelitis.
    Schiff ND; Moore DF; Winterkorn JM
    J Neuroophthalmol; 1996 Dec; 16(4):302-3. PubMed ID: 8956170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.